Allmed Medical Products Co Ltd Class A (002950) - Net Assets

Latest as of March 2026: CN¥3.72 Billion CNY ≈ $544.59 Million USD

Based on the latest financial reports, Allmed Medical Products Co Ltd Class A (002950) has net assets worth CN¥3.72 Billion CNY (≈ $544.59 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.90 Billion ≈ $863.84 Million USD) and total liabilities (CN¥2.18 Billion ≈ $319.25 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is Allmed Medical Products Co Ltd Class A's balance sheet for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥3.72 Billion
% of Total Assets	63.04%
Annual Growth Rate	15.48%
5-Year Change	31.35%
10-Year Change	254.94%
Growth Volatility	18.35

Allmed Medical Products Co Ltd Class A - Net Assets Trend (2014–2025)

This chart illustrates how Allmed Medical Products Co Ltd Class A's net assets have evolved over time, based on quarterly financial data. Check how tangible is Allmed Medical Products Co Ltd Class A's equity to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Allmed Medical Products Co Ltd Class A (2014–2025)

The table below shows the annual net assets of Allmed Medical Products Co Ltd Class A from 2014 to 2025. For live valuation and market cap data, see 002950 market cap overview.

Year	Net Assets	Change
2025-12-31	CN¥3.61 Billion ≈ $528.96 Million	+4.84%
2024-12-31	CN¥3.45 Billion ≈ $504.56 Million	+7.38%
2023-12-31	CN¥3.21 Billion ≈ $469.86 Million	+2.55%
2022-12-31	CN¥3.13 Billion ≈ $458.16 Million	+13.77%
2021-12-31	CN¥2.75 Billion ≈ $402.71 Million	-5.85%
2020-12-31	CN¥2.92 Billion ≈ $427.74 Million	+41.96%
2019-12-31	CN¥2.06 Billion ≈ $301.32 Million	+55.80%
2018-12-31	CN¥1.32 Billion ≈ $193.40 Million	+20.31%
2017-12-31	CN¥1.10 Billion ≈ $160.75 Million	+7.87%
2016-12-31	CN¥1.02 Billion ≈ $149.03 Million	+2.44%
2015-12-31	CN¥994.18 Million ≈ $145.48 Million	+33.97%
2014-12-31	CN¥742.08 Million ≈ $108.59 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Allmed Medical Products Co Ltd Class A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 635.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥2.25 Billion	62.46%
Other Components	CN¥1.35 Billion	37.54%
Total Equity	CN¥3.60 Billion	100.00%

Allmed Medical Products Co Ltd Class A Competitors by Market Cap

The table below lists competitors of Allmed Medical Products Co Ltd Class A ranked by their market capitalization.

Company	Market Cap
Kodiak AI, Inc. Common Stock NASDAQ:KDK	$824.75 Million
Mingyue Optical Lens Co.Ltd. SHE:301101	$825.06 Million
Yunding Technology Co Ltd SHE:000409	$825.15 Million
Pricol Limited NSE:PRICOLLTD	$825.26 Million
Truking Technology Ltd SHE:300358	$824.57 Million
Festi hf IC:FESTI	$824.37 Million
Standard Foods Corp TW:1227	$824.26 Million
Kri-Kri Milk Industry S.A AT:KRI	$824.15 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Allmed Medical Products Co Ltd Class A's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 3,436,525,341 to 3,595,058,488, a change of 158,533,147 (4.6%).
Net income of 248,884,077 contributed positively to equity growth.
Dividend payments of 52,342,574 reduced retained earnings.
Other comprehensive income decreased equity by 302,309,265.
Other factors increased equity by 264,300,909.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥248.88 Million	+6.92%
Dividends Paid	CN¥52.34 Million	-1.46%
Other Comprehensive Income	CN¥-302.31 Million	-8.41%
Other Changes	CN¥264.30 Million	+7.35%
Total Change	CN¥-	4.61%

Book Value vs Market Value Analysis

This analysis compares Allmed Medical Products Co Ltd Class A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.57x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 7.14x to 1.57x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	CN¥1.25	CN¥8.90	x
2015-12-31	CN¥1.69	CN¥8.90	x
2016-12-31	CN¥1.73	CN¥8.90	x
2017-12-31	CN¥1.94	CN¥8.90	x
2018-12-31	CN¥2.34	CN¥8.90	x
2019-12-31	CN¥3.33	CN¥8.90	x
2020-12-31	CN¥4.60	CN¥8.90	x
2021-12-31	CN¥4.35	CN¥8.90	x
2022-12-31	CN¥4.90	CN¥8.90	x
2023-12-31	CN¥5.03	CN¥8.90	x
2024-12-31	CN¥5.50	CN¥8.90	x
2025-12-31	CN¥5.68	CN¥8.90	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Allmed Medical Products Co Ltd Class A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.92%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 6.78%
• Asset Turnover: 0.65x
• Equity Multiplier: 1.56x
Recent ROE (6.92%) is below the historical average (17.70%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	27.36%	13.15%	0.86x	2.41x	CN¥125.91 Million
2015	15.99%	9.90%	0.86x	1.88x	CN¥58.82 Million
2016	24.63%	15.93%	0.82x	1.88x	CN¥147.39 Million
2017	21.48%	13.66%	0.75x	2.09x	CN¥124.94 Million
2018	17.35%	11.23%	0.70x	2.21x	CN¥96.52 Million
2019	15.88%	13.85%	0.75x	1.54x	CN¥120.64 Million
2020	39.77%	30.19%	0.79x	1.67x	CN¥866.46 Million
2021	15.66%	14.74%	0.58x	1.82x	CN¥155.92 Million
2022	13.12%	9.66%	0.73x	1.85x	CN¥96.68 Million
2023	3.46%	4.00%	0.54x	1.60x	CN¥-208.32 Million
2024	10.73%	11.08%	0.66x	1.47x	CN¥25.03 Million
2025	6.92%	6.78%	0.65x	1.56x	CN¥-110.62 Million

Industry Comparison

This section compares Allmed Medical Products Co Ltd Class A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $1,910,528,305
Average return on equity (ROE) among peers: 6.54%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Allmed Medical Products Co Ltd Class A (002950)	CN¥3.72 Billion	27.36%	0.59x	$824.73 Million
Beijing Centergate Technologies Holding Co Ltd (000931)	$2.13 Billion	7.47%	2.10x	$458.46 Million
Blue Sail Medical Co Ltd (002382)	$1.30 Billion	13.93%	0.22x	$834.52 Million
Andon Health Co Ltd (002432)	$775.55 Million	2.68%	0.08x	$5.00 Billion
Guangzhou Improve Med Instrument (300030)	$820.61 Million	-24.16%	0.90x	$270.56 Million
QITIAN Technology Group Co Ltd (300061)	$64.46 Million	19.72%	1.76x	$578.59 Million
Shanghai Tofflon Science Tech (300171)	$8.11 Billion	7.40%	0.59x	$1.32 Billion
Truking Technology Ltd (300358)	$2.41 Billion	1.94%	0.86x	$824.57 Million
Jiangxi Sanxin Medtec Co Ltd (300453)	$1.33 Billion	15.49%	0.52x	$719.66 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573)	$247.00 Million	14.43%	0.08x	$1.45 Billion

About Allmed Medical Products Co Ltd Class A

SHE:002950 China Medical Instruments & Supplies

Market Cap

$824.73 Million

CN¥5.64 Billion CNY

Market Cap Rank

#9592 Global

#2371 in China

Share Price

CN¥8.90

Change (1 day)

+1.60%

52-Week Range

CN¥8.66 - CN¥14.59

All Time High

CN¥33.73